GlassScriptPhysician profile
Rebekah Robinson
NPI 1942632435
$554.36
in general payments reported to CMS, 2019-2025
7 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.46 · 2022: $25.84 · 2023: $160 · 2024: $15.94 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $194.20 | 2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Abbott Laboratories | $111.30 | 2021-2022 | |
| Silk Road Medical, INC. | $72.84 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Medtronic, INC. | $60.67 | 2023 | Endurant Iis |
| Surgenex LLC | $53.14 | 2025 | Surgraft, Surmatrix, Pellograft |
| W. L. Gore & Associates, INC. | $36.11 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Ethicon US, LLC | $26.10 | 2023 | Harmonic, Ethicon, Prolene |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebekah Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.